THYROID TABLETS USP
FDA recalls Vitruvias thyroid tablets after testing finds potential ‘superpotency’; here’s who faces greater riskVitruvias Therapeutics has announced a voluntary recall of its thyroid tablets after tests indicated the potential for superpotency, which ...
Zydus Cadila gets USFDA nod for thyroid drugZydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg,...
Lupin launches Levothyroxine Sodium tablets in USThe tablets are indicated as replacement or supplemental therapy for hypothyroidism.
- Load More